Preservation of CD20-Specific Chimeric Antigen Receptor T Cell Function in the Presence of Residual Rituximab

Overview of attention for article published in Blood, December 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (77th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

patent: 6 patents

Readers on

mendeley: 3 Mendeley

So far, Altmetric has seen 6 patents that reference this research output.

Compositions and methods for CD20 immunotherapy

Grant JP-7397840-B2

Japan

13 Dec 2023

Compositions and methods for CD20 immunotherapy

Grant US-11834511-B2

United States of America

05 Dec 2023

Compositions and Methods for CD20 Immunotherapy

Grant JP-7065782-B2

Japan

12 May 2022

Compositions and Methods for CD20 Immunotherapy

Application JP-2022002550-A

Japan

11 Jan 2022

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 2 additional patents.